Previous Page
12-03 :: March/April 2012
nanotimes
Companies Facts
The Company is currently producing a 1kg batch of the green quantum dots, which, once produced and validated by the customer, will attract a US$2 million payment. It is expected that the 1kg of green quantum dots will be delivered during the current half year. In April last year, Nanoco received a US$2 million payment from the corporation for 1kg of red quantum dots. This was a major technical bre- akthrough, and a world first in that quantum dots had never before been manufactured in this batch size. The intention of this major Japanese corporation is to combine the bespoke red and green quantum dots with blue LEDs to produce a highly efficient source of white light for multiple applications, for use in both general lighting and in backlighting LCD displays.
anogate AG (N7G) has made a significant break- through in its work to open up the volume mar-
ket for the energy efficiency application field: Nanogate is to start selling the new energy efficiency coatings after all systems were approved by the marketing and technology partners. The Group will first concentrate on the attractive market for energy- saving heating systems. Nanogate expects to sign a number of key contracts shortly and to achieve sales in the seven-figure euro range in the medium term. In connection with this, Nanogate is also planning to expand its capacity in German Federal State Saar- land. The result of this may be the creation of up to fifty new jobs, primarily in production and surface coating.
anoString Technologies, Inc., launched three new products for the nCounter®
29
Analysis Sy-
stem at the American Association of Cancer Research (AACR) Annual Meeting 2012, March 31-April 4. NanoString’s suite of new products accelerates sam- ple throughput for validation studies, enhances copy number studies using FFPE archival samples, and pro- vides the latest content for human microRNA assays. The nCounter Plex2 Expression Assay Kit increases the throughput of the nCounter system four-fold by using barcodes to multiplex in two dimensions, across both samples and mRNA targets.
The nCounter Cancer Copy Number Assay Kit ena- bles precise analysis of 86 genes that are commonly amplified or deleted in many cancer types, including: PIK3CA, AKT, PTEN, BRCA, and MYC. It is optimized for analysis of FFPE samples and maintains the trade- mark ease-of-use of all other nCounter assays.
The nCounter Human v2 miRNA Expression Assay Kit updates NanoString’s most popular miRNA ex- pression kit with content from miRBase 18. The kit allows investigators to profile 800 of the most highly expressed miRNAs in a single tube without the need for amplification.
Moreover, NanoString Technologies announced the appointment of Joseph M. Beechem, Ph.D. as Senior Vice President of Research and Develop- ment.